Kabilar Gunalan1, Cameron C McIntyre2. 1. Department of Biomedical Engineering, Case Western Reserve University, Cleveland, OH, USA. 2. Department of Biomedical Engineering, Case Western Reserve University, Cleveland, OH, USA. Electronic address: ccm4@case.edu.
Abstract
OBJECTIVE: Direct activation of the hyperdirect (HD) pathway has been linked to therapeutic benefit from subthalamic deep brain stimulation (DBS) for the treatment of Parkinson's disease (PD). We sought to quantify the axonal conduction biophysics of corticofugal axons directly stimulated by subthalamic DBS and reconcile those findings with short-latency cortical evoked potential (EP) results. METHODS: We used a detailed computational model of human subthalamic DBS to quantify axonal activation and conduction. Signal propagation to cortex was evaluated for medium (5.7 µm), large (10.0 µm), and exceptionally large (15.0 µm) diameter corticofugal axons associated with either internal capsule (IC) fibers of passage or the HD pathway. We then compared the modeling results to human cortical EP measurements that have described an exceptionally fast component (EP0) occurring ~1 ms after the stimulus pulse, a fast component (EP1) at ~3 ms, and a slower component (EP2) at ~5 ms. RESULTS: Subthalamic stimulation of the HD pathway with large and medium diameter axons propagated action potentials to cortex with timings that coincide with the EP1 and EP2 signals, respectively. Only direct activation of exceptionally large diameter fibers in the IC generated signals that could approach the EP0 timing. However, the action potential biophysics do not generally support the existence of a cortical EP less than 1.5 ms after DBS onset. CONCLUSIONS: The EP1 and EP2 signals can be biophysically linked to antidromic activation of the HD pathway. SIGNIFICANCE: Theoretical reconstruction of cortical EPs from subthalamic DBS demonstrate a convergence of anatomical, biophysical, and electrophysiological results.
OBJECTIVE: Direct activation of the hyperdirect (HD) pathway has been linked to therapeutic benefit from subthalamic deep brain stimulation (DBS) for the treatment of Parkinson's disease (PD). We sought to quantify the axonal conduction biophysics of corticofugal axons directly stimulated by subthalamic DBS and reconcile those findings with short-latency cortical evoked potential (EP) results. METHODS: We used a detailed computational model of human subthalamic DBS to quantify axonal activation and conduction. Signal propagation to cortex was evaluated for medium (5.7 µm), large (10.0 µm), and exceptionally large (15.0 µm) diameter corticofugal axons associated with either internal capsule (IC) fibers of passage or the HD pathway. We then compared the modeling results to human cortical EP measurements that have described an exceptionally fast component (EP0) occurring ~1 ms after the stimulus pulse, a fast component (EP1) at ~3 ms, and a slower component (EP2) at ~5 ms. RESULTS: Subthalamic stimulation of the HD pathway with large and medium diameter axons propagated action potentials to cortex with timings that coincide with the EP1 and EP2 signals, respectively. Only direct activation of exceptionally large diameter fibers in the IC generated signals that could approach the EP0 timing. However, the action potential biophysics do not generally support the existence of a cortical EP less than 1.5 ms after DBS onset. CONCLUSIONS: The EP1 and EP2 signals can be biophysically linked to antidromic activation of the HD pathway. SIGNIFICANCE: Theoretical reconstruction of cortical EPs from subthalamic DBS demonstrate a convergence of anatomical, biophysical, and electrophysiological results.
Authors: Abraham Mathai; Yuxian Ma; Jean-Francois Paré; Rosa M Villalba; Thomas Wichmann; Yoland Smith Journal: Brain Date: 2015-02-12 Impact factor: 13.501
Authors: G Tommasi; P Krack; V Fraix; J-F Le Bas; S Chabardes; A-L Benabid; P Pollak Journal: J Neurol Neurosurg Psychiatry Date: 2007-10-10 Impact factor: 10.154
Authors: Svjetlana Miocinovic; Scott F Lempka; Gary S Russo; Christopher B Maks; Christopher R Butson; Ken E Sakaie; Jerrold L Vitek; Cameron C McIntyre Journal: Exp Neurol Date: 2008-12-11 Impact factor: 5.330
Authors: Nicole C Swann; Coralie de Hemptinne; Margaret C Thompson; Svjetlana Miocinovic; Andrew M Miller; Ro'ee Gilron; Jill L Ostrem; Howard J Chizeck; Philip A Starr Journal: J Neural Eng Date: 2018-05-09 Impact factor: 5.379
Authors: Bryan Howell; Faical Isbaine; Jon T Willie; Enrico Opri; Robert E Gross; Coralie De Hemptinne; Philip A Starr; Cameron C McIntyre; Svjetlana Miocinovic Journal: Brain Stimul Date: 2021-03-20 Impact factor: 8.955
Authors: Brett A Campbell; Leonardo Favi Bocca; David Escobar Sanabria; Julio Almeida; Richard Rammo; Sean J Nagel; Andre G Machado; Kenneth B Baker Journal: Front Hum Neurosci Date: 2022-09-20 Impact factor: 3.473